142 related articles for article (PubMed ID: 401339)
1. Monitoring of antidepressant drug plasma levels: the next ten years.
Sjöqvist F
Prog Neuropsychopharmacol; 1979; 3(1-3):201-10. PubMed ID: 401339
[TBL] [Abstract][Full Text] [Related]
2. The role of plasma concentrations in the use of tricyclic antidepressant drugs.
Levine RR
Prog Neuropsychopharmacol; 1979; 3(1-3):211-22. PubMed ID: 401340
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of tricyclic antidepressants in clinical practice.
Hollister LE
J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
[TBL] [Abstract][Full Text] [Related]
4. Plasma drug levels and clinical response to antidepressants.
Simpson GM; Pi EH; White K
J Clin Psychiatry; 1983 May; 44(5 Pt 2):27-34. PubMed ID: 6343361
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
Lydiard RB
J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
[TBL] [Abstract][Full Text] [Related]
6. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.
Am J Psychiatry; 1985 Feb; 142(2):155-62. PubMed ID: 3881999
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties].
Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
Psychiatr Pol; 1993; 27(6):683-91. PubMed ID: 8134502
[TBL] [Abstract][Full Text] [Related]
9. Monitoring tricyclic antidepressant plasma concentrations.
Hollister LE
JAMA; 1979 Jun; 241(23):2530-3. PubMed ID: 439339
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic antidepressant plasma levels: the state of the art and clinical prospects.
Razavi D; Mendlewicz J
Neuropsychobiology; 1982; 8(2):73-85. PubMed ID: 7070646
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic monitoring of tricyclic antidepressant drugs].
Grzesiak M; Beszłej JA; Szewczuk-Bogusławska M
Psychiatr Pol; 2003; 37(5):825-37. PubMed ID: 14631602
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of tricyclic antidepressants in clinical practice.
J Clin Psychiatry; 1982 Sep; 43(9):389-90. PubMed ID: 7118847
[No Abstract] [Full Text] [Related]
13. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic monitoring of antidepressant drugs: guidelines updated.
Orsulak PJ
Ther Drug Monit; 1989 Sep; 11(5):497-507. PubMed ID: 2683251
[TBL] [Abstract][Full Text] [Related]
15. Current antidepressant drugs: their clinical use.
Hollister LE
Drugs; 1981 Aug; 22(2):129-52. PubMed ID: 6114851
[TBL] [Abstract][Full Text] [Related]
16. The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis.
Perry PJ; Pfohl BM; Holstad SG
Clin Pharmacokinet; 1987 Dec; 13(6):381-92. PubMed ID: 3325215
[TBL] [Abstract][Full Text] [Related]
17. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.
Rubin EH; Biggs JT; Preskorn SH
J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052
[TBL] [Abstract][Full Text] [Related]
18. Indications and guidelines for plasma tricyclic antidepressant concentration monitoring.
Risch SC; Kalin NH; Janowsky DS; Huey LY
J Clin Psychopharmacol; 1981 Mar; 1(2):59-63. PubMed ID: 7298884
[TBL] [Abstract][Full Text] [Related]
19. Monitoring tricyclic antidepressants.
Sjöqvist F; Bertilsson L; Asberg M
Ther Drug Monit; 1980; 2(1):85-93. PubMed ID: 6762705
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
Preskorn SH; Fast GA
J Clin Psychiatry; 1991 Jun; 52 Suppl():23-33. PubMed ID: 1904862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
